Molecules (Jan 2021)

Anticancer Potential of <i>Sutherlandia frutescens</i> and <i>Xysmalobium undulatum</i> in LS180 Colorectal Cancer Mini-Tumors

  • Chrisna Gouws,
  • Tanya Smit,
  • Clarissa Willers,
  • Hanna Svitina,
  • Carlemi Calitz,
  • Krzysztof Wrzesinski

DOI
https://doi.org/10.3390/molecules26030605
Journal volume & issue
Vol. 26, no. 3
p. 605

Abstract

Read online

Colorectal cancer remains to be one of the leading causes of death worldwide, with millions of patients diagnosed each year. Although chemotherapeutic drugs are routinely used to treat cancer, these treatments have severe side effects. As a result, the use of herbal medicines has gained increasing popularity as a treatment for cancer. In this study, two South African medicinal plants widely used to treat various diseases, Sutherlandia frutescens and Xysmalobium undulatum, were evaluated for potential activity against colorectal cancer. This potential activity for the treatment of colorectal cancer was assessed relative to the known chemotherapeutic drug, paclitaxel. The cytotoxic activity was considered in an advanced three-dimensional (3D) sodium alginate encapsulated LS180 colorectal cancer functional spheroid model, cultured in clinostat-based rotating bioreactors. The LS180 cell mini-tumors were treated for 96 h with two concentrations of each of the crude aqueous extracts or paclitaxel. S. frutescens extract markedly decreased the soluble protein content, while decreasing ATP and AK per protein content to below detectable limits after only 24 h exposure. X. undulatum extract also decreased the soluble protein content, cell viability, and glucose consumption. The results suggested that the two phytomedicines have potential to become a source of new treatments against colorectal cancer.

Keywords